Literature DB >> 2586018

Interference of different ACE-inhibitors with the diuretic action of furosemide and hydrochlorothiazide.

C Toussaint1, A Masselink, A Gentges, G Wambach, G Bönner.   

Abstract

In healthy volunteers the acute effect of furosemide (40 mg i.v.) and hydrochlorothiazide (100 mg p.o.) on diuresis, natriuresis and renal kallikrein and kinin excretion was investigated. Furosemide stimulated markedly diuresis and natriuresis as well as urinary kallikrein and kinin excretion. Pretreatment by captopril (C) reduced the diuretic and natriuretic effect of furosemide significantly probably due to a diminished (about 50%) proximal-tubular secretion of furosemide. Captopril did not alter significantly the furosemide induced changes in urinary kallikrein and kinin excretion. After captopril there was a clear dissociation between aldosterone, which was diminished by captopril continuously, and renal kallikrein and kinins, which were still stimulated by furosemide. These results suggest that renal kallikrein-kinin system is stimulated by furosemide directly and independently of aldosterone secretion. Other ACE-inhibitors like ramipril (5 mg) or enalapril (20 mg) did not influence the stimulatory effects of furosemide on diuresis or kallikrein-kinin excretion. Ramipril at a dose of 10 mg, however, enhanced the initial diuretic effect of furosemide by increased furosemide secretion and increased relative sodium excretion. Hydrochlorothiazide induced a prolonged diuresis which was not changed by either captopril or ramipril. Urinary kallikrein excretion was not stimulated by hydrochlorothiazide. Our results show an important drug interference between captopril and furosemide, which is independent of ACE-inhibition and probably only due to an interference in proximal-tubular secretion of both drugs. Between captopril and hydrochlorothiazide no such interaction could be observed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2586018     DOI: 10.1007/bf01726115

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  26 in total

1.  A simple radioassay for angiotensin-converting enzyme.

Authors:  J W Ryan; A Chung; C Ammons; M L Carlton
Journal:  Biochem J       Date:  1977-11-01       Impact factor: 3.857

2.  Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers.

Authors:  I De Lepeleire; A Van Hecken; R Verbesselt; G Kaiser; A Barner; I Holmes; P J De Schepper
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Measurement of furosemide by high-performance liquid chromatography.

Authors:  S E Swezey; P J Meffin; T F Blaschke
Journal:  J Chromatogr       Date:  1979-07-01

4.  Effects of frusemide on the renal kallikrein-kinin system of the rat.

Authors:  G Bönner; D Beck; M Deeg; M Marin-Grez; F Gross
Journal:  Clin Sci (Lond)       Date:  1982-11       Impact factor: 6.124

Review 5.  The renal kallikrein-kinin system.

Authors:  O A Carretero; A G Scicli
Journal:  Am J Physiol       Date:  1980-04

6.  Inhibition of renal clearance of furosemide by pentopril, an angiotensin-converting enzyme inhibitor.

Authors:  A Rakhit; G M Kochak; V Tipnis; M E Hurley
Journal:  Clin Pharmacol Ther       Date:  1987-05       Impact factor: 6.875

7.  Relationship between kallikrein and PRA after intravenous furosemide.

Authors:  G A Cinotti; G Stirati; F Taggi; R Ronci; B M Simonetti; A Pierucci
Journal:  J Endocrinol Invest       Date:  1979 Apr-Jun       Impact factor: 4.256

8.  Urinary kallikrein activity and renal vascular resistance in the antihypertensive response to thiazide diuretics.

Authors:  D T O'Connor; R A Preston; J A Mitas; R P Frigon; R A Stone
Journal:  Hypertension       Date:  1981 Jan-Feb       Impact factor: 10.190

Review 9.  The renal kallikrein-kinin system in human and in experimental hypertension.

Authors:  O A Carretero; A G Scicli
Journal:  Klin Wochenschr       Date:  1978

10.  The influence of isotonic saline administration on the urinary excretion of kallikrein in rats.

Authors:  M Marin-Grez; G Bönner; F Gross
Journal:  Biochem Pharmacol       Date:  1984-11-15       Impact factor: 5.858

View more
  6 in total

Review 1.  ACE inhibitors. Drug interactions of clinical significance.

Authors:  C Mignat; T Unger
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

Review 2.  Loop diuretics versus others in the treatment of congestive heart failure after myocardial infarction.

Authors:  A J Reyes
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

3.  Captopril augments both basal and frusemide-induced natriuresis in normal man by suppression of circulating angiotensin II.

Authors:  J G Motwani; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

4.  The influence of hydrochlorothiazide on the pharmacokinetics of enalapril in elderly patients.

Authors:  K Weisser; J Schloos; S Jakob; W Mühlberg; D Platt; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Effects of angiotensin-converting enzyme inhibition on renal sodium handling after furosemide injection.

Authors:  R Nowack; D Fliser; J Richter; C Horne; E Mutschler; E Ritz
Journal:  Clin Investig       Date:  1993-08

Review 6.  Pharmacokinetic drug interactions with ACE inhibitors.

Authors:  H Shionoiri
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.